INTERNATIONAL PATENT: DRUG TARGET IP B.V. FILES APPLICATION FOR "AGENTS THAT CAN BIND ELAV4 FOR USE IN THE TREATMENT OF TAUOPATHIES"

GENEVA, May 15 -- DRUG TARGET IP B.V. (Toernooiveld 3006525 EC Nijmegen) filed a patent application (PCT/EP2024/080927) for "AGENTS THAT CAN BIND ELAV4 FOR USE IN THE TREATMENT OF TAUOPATHIES" on Nov 01, 2024. With publication no. WO/2025/093735, the details related to the patent application was published on May 08, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): POELMANS, Geert Jan Vital (Toernooiveld 3006525 EC NIJMEGEN), VAN DER LINDEN, Robert Jan (Toernooiveld 3006525 EC NIJMEGEN), KLEMANN, Cornelius Jacobus Hendricus Maria (Toernooiveld 3006525 EC NIJMEGEN), DE WITTE, Ward (Toernooiveld...